Navigation Links
MC Leeuwarden Selects ClinicalKey
Date:1/28/2013

AMSTERDAM, January 28, 2013 /PRNewswire/ --

Hospital in the Netherlands provides 650 clinicians access to Elsevier's 'clinical insight engine,' which delivers the most current clinically relevant, evidence-based answers

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that MC Leeuwarden will provide its 650 clinicians with access to ClinicalKey, Elsevier's pioneering "clinical insight engine." MC Leeuwarden is part of a select group of hospitals in the Netherlands called the STZ (the association of tertiary medical teaching hospitals).

Under the terms of the agreement, MC Leeuwarden will have access to ClinicalKey the tool's content, which includes more than 900 textbooks, 500 top medical journals and 9,000 procedural videos, providing the most current clinically relevant evidence-based answers, as well as expert commentary, MEDLINE abstracts and select third-party journals.

"Fast access to the most current up-to-date medical and scientific information is a vital element for clinician's in their daily workflow.  We were really impressed with ClinicalKey and what it has to offer," said Jelle Prins , Dean of the MC Leeuwarden Academy.  "Clinical excellence is a big priority for us, and we are confident that this tool can help us to get access to the core-information and that it will provide our professionals with the latest state-of-the-art functionality.  The way in which ClinicalKey presents its information is of real added value to our clinicians and organization."

Launched in April 2012, ClinicalKey provides the most current clinically relevant evidence-based answers, as well as expert commentary, MEDLINE abstracts and select third-party journals. Its clinical reference search engine is powered by Elsevier's Smart Content, tagged with EMMeT (Elsevier Merged Medical Taxonomy), which enables ClinicalKey to understand clinical terms and thus discover medical content that is the most relevant, plus find related content that would be missed by other search engines. Clinicians, professors and medical students are able to quickly move from topic overview to in-depth specialty information in order to meet every day clinical challenges.

"MC Leeuwarden is one of the progressive institutions in the Netherlands, and we are proud that it selected ClinicalKey for its clinical reference needs," said Sebastian Vos , Senior Vice President, e-Solutions, EMEA-LA, Health Science at Elsevier.  "Our content is comprehensive, trusted and quick, and this will help MC Leeuwarden find the most accurate response to help advance their training and ultimately, improve patient care."

For more information about ClinicalKey, visit http://info.clinicalkey.com

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby's Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Christopher Capot
Director, Corporate Relations
Elsevier
+1-212-633-3164
c.capot@elsevier.com


'/>"/>
SOURCE Elsevier
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Islet Sciences, Inc. Selects NeoStems Manufacturing Subsidiary Progenitor Cell Therapy for Product Manufacturing
2. Netsmart Selects Overland Park, Kansas, for New Office
3. Pharmaceutical Consortium Selects BioFortis Software to Manage Collaborative Clinical Data and Biobanking Activities
4. Maine Center for Creativity Selects Glenn Close and David Shaw to Receive Inaugural Maine Creative Industry Award
5. Aesthetics Pharmaceutical Company Selects 360 Vantage Closed Loop Marketing Solution for Apple iPad
6. Eaton Apothecary Selects Predictive Acquisition Cost (PAC) Drug Price Type
7. Bellicum Selects DATATRAK Solution for Drug Program
8. University of California, San Francisco (UCSF) Selects Conflict of Interest Management System
9. INC Research Selects MetricStream to Strengthen Compliance Management
10. Genomatica, Inc., Award-Winning Industrial Biotechnology Pioneer, Selects Alexandria Real Estate Equities, Inc. for Long-Term, Mission-Critical R&D Facility and Corporate Headquarters
11. Moscow State University Hospital Selects Ekahau RTLS to Improve Operations and Patient Safety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Mar 23, 2017 Research and Markets ... Markets" report to their offering. ... The Global Market for ... in 2016 at a CAGR of 8.9%, ... non-energetic bioproducts into seven major product segments: bio-derived chemicals, biofuels, ...
(Date:3/23/2017)... , March 23, 2017  SeraCare Life ... global in vitro diagnostics manufacturers and clinical ... industry,s first multiplexed Inherited Cancer reference ... by next-generation sequencing (NGS). The Seraseqâ„¢ Inherited ... with input from industry experts to validate ...
(Date:3/23/2017)... 2017  BioPharmX Corporation (NYSE MKT: BPMX), a ... market, today reported financial results for the quarter ... provide an update on the company,s clinical development ... "We are pleased to report that last year ... President Anja Krammer. "We achieved key clinical milestones ...
(Date:3/23/2017)... SEATTLE , March 23, 2017 ... translational development of novel therapies in immuno-oncology, today ... to lead" small molecule compounds that activate interferon ... (RLR) pathways and demonstrate immune-mediated tumor regression in ... in the study who demonstrated complete tumor regression ...
Breaking Biology Technology:
(Date:3/7/2017)... England , March 7, 2017 Brandwatch , ... chosen by The Prince,s Trust to uncover insights to ... across The Trust. The UK,s leading youth charity will ... social campaign results and get a better understanding of the topics ... ...
(Date:3/2/2017)... Summary This report provides all ... and its partnering interests and activities since 2010. ... The Partnering Deals and Alliance since 2010 report provides ... of the world,s leading life sciences companies. ... ensure inclusion of the most up to date deal ...
(Date:2/28/2017)... 2017   Acuant , a leading provider of ... enhancements to new and core technologies building upon the ... mobile and desktop Acuant FRM TM facial recognition ... real time manual review of identity documents by accredited ... fastest and most accurate capture software to streamline workflows ...
Breaking Biology News(10 mins):